Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hes1
|
ENSMUSG00000022528.7 | Hes1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
Hes1 | chr16_30063273_30064853 | 321 | 0.864602 | 0.75 | 8.1e-12 | Click! |
Hes1 | chr16_30070539_30070971 | 4417 | 0.175057 | 0.64 | 3.3e-08 | Click! |
Hes1 | chr16_30065930_30067103 | 178 | 0.935740 | 0.58 | 1.1e-06 | Click! |
Hes1 | chr16_30067937_30069024 | 2142 | 0.255186 | 0.55 | 5.1e-06 | Click! |
Hes1 | chr16_30067214_30067410 | 974 | 0.494061 | 0.54 | 9.6e-06 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_75176309_75177605 | 7.55 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr3_62603065_62604257 | 5.53 |
Gpr149 |
G protein-coupled receptor 149 |
887 |
0.72 |
chr2_173275041_173276225 | 5.26 |
Pmepa1 |
prostate transmembrane protein, androgen induced 1 |
556 |
0.64 |
chr2_178141581_178143125 | 5.13 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr11_118908287_118909561 | 5.06 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr13_51594475_51595717 | 4.96 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25609 |
0.16 |
chr2_149830330_149831719 | 4.89 |
Syndig1 |
synapse differentiation inducing 1 |
102 |
0.63 |
chr1_166308788_166309685 | 4.80 |
5330438I03Rik |
RIKEN cDNA 5330438I03 gene |
349 |
0.87 |
chr15_95527528_95528774 | 4.73 |
Nell2 |
NEL-like 2 |
27 |
0.99 |
chr16_60605121_60606481 | 4.71 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr13_83727321_83728283 | 4.66 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
304 |
0.83 |
chr5_26817077_26818245 | 4.36 |
Dpp6 |
dipeptidylpeptidase 6 |
227 |
0.94 |
chr1_38835637_38836715 | 4.27 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
198 |
0.94 |
chr7_79498955_79500626 | 4.26 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr18_56774248_56775286 | 4.03 |
Gm15345 |
predicted gene 15345 |
5050 |
0.22 |
chr18_86712592_86713744 | 3.97 |
Cbln2 |
cerebellin 2 precursor protein |
120 |
0.98 |
chr4_57567646_57569018 | 3.96 |
Pakap |
paralemmin A kinase anchor protein |
2 |
0.99 |
chr17_93198991_93201483 | 3.67 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr10_49787984_49789251 | 3.66 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
137 |
0.6 |
chr3_31309226_31310664 | 3.60 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr4_103619552_103620735 | 3.59 |
Dab1 |
disabled 1 |
478 |
0.8 |
chr2_113828248_113829427 | 3.59 |
Scg5 |
secretogranin V |
75 |
0.97 |
chr3_73056547_73057799 | 3.52 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
230 |
0.93 |
chr17_7826723_7827946 | 3.49 |
Fndc1 |
fibronectin type III domain containing 1 |
32 |
0.98 |
chr16_97169746_97171103 | 3.48 |
Dscam |
DS cell adhesion molecule |
328 |
0.94 |
chr9_102353147_102354512 | 3.42 |
Ephb1 |
Eph receptor B1 |
864 |
0.59 |
chr10_29143400_29144848 | 3.35 |
Soga3 |
SOGA family member 3 |
65 |
0.5 |
chr13_119755269_119755588 | 3.28 |
Nim1k |
NIM1 serine/threonine protein kinase |
454 |
0.54 |
chr7_127823788_127824540 | 3.27 |
Stx4a |
syntaxin 4A (placental) |
130 |
0.74 |
chr7_131966504_131967699 | 3.26 |
Gpr26 |
G protein-coupled receptor 26 |
641 |
0.75 |
chr5_112576144_112577196 | 3.25 |
Sez6l |
seizure related 6 homolog like |
198 |
0.92 |
chr6_145075061_145076261 | 3.25 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
523 |
0.72 |
chr17_43629214_43630519 | 3.22 |
Tdrd6 |
tudor domain containing 6 |
400 |
0.83 |
chr7_45870455_45871042 | 3.21 |
Grin2d |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) |
319 |
0.72 |
chr18_67133061_67134333 | 3.19 |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
53 |
0.96 |
chr16_94124910_94125992 | 3.15 |
Sim2 |
single-minded family bHLH transcription factor 2 |
270 |
0.88 |
chr18_35964551_35965976 | 3.13 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr10_41070697_41071486 | 3.10 |
Gpr6 |
G protein-coupled receptor 6 |
1194 |
0.41 |
chr9_43746633_43747189 | 3.10 |
Gm30015 |
predicted gene, 30015 |
811 |
0.54 |
chr10_125967796_125968797 | 3.09 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2043 |
0.45 |
chr9_117871858_117873400 | 3.04 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
45 |
0.91 |
chr11_33842610_33843965 | 3.02 |
Kcnip1 |
Kv channel-interacting protein 1 |
174 |
0.97 |
chr14_44858459_44859503 | 3.02 |
Gm16976 |
predicted gene, 16976 |
27 |
0.85 |
chr9_10903843_10905236 | 3.02 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chr4_49844475_49845850 | 3.01 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
387 |
0.91 |
chr5_113490881_113491656 | 3.01 |
Wscd2 |
WSC domain containing 2 |
516 |
0.83 |
chr19_48205036_48205839 | 2.99 |
Sorcs3 |
sortilin-related VPS10 domain containing receptor 3 |
588 |
0.8 |
chr12_119945587_119946924 | 2.98 |
Tmem196 |
transmembrane protein 196 |
155 |
0.95 |
chr4_73790300_73791129 | 2.98 |
Rasef |
RAS and EF hand domain containing |
5 |
0.91 |
chr5_38158478_38159481 | 2.96 |
Nsg1 |
neuron specific gene family member 1 |
52 |
0.97 |
chr11_49793921_49795269 | 2.93 |
Gfpt2 |
glutamine fructose-6-phosphate transaminase 2 |
408 |
0.8 |
chr6_120492177_120492905 | 2.91 |
Tmem121b |
transmembrane protein 121B |
1266 |
0.34 |
chr9_112235046_112235787 | 2.89 |
Arpp21 |
cyclic AMP-regulated phosphoprotein, 21 |
398 |
0.75 |
chr11_96338771_96339811 | 2.89 |
Hoxb3 |
homeobox B3 |
1654 |
0.16 |
chr2_113757445_113759087 | 2.89 |
Grem1 |
gremlin 1, DAN family BMP antagonist |
380 |
0.87 |
chr6_42708913_42710173 | 2.89 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
528 |
0.62 |
chr11_108925496_108926003 | 2.86 |
Axin2 |
axin 2 |
2568 |
0.3 |
chr16_28564192_28565135 | 2.86 |
Fgf12 |
fibroblast growth factor 12 |
288 |
0.94 |
chr16_9994378_9995594 | 2.84 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr5_47984794_47986445 | 2.84 |
Slit2 |
slit guidance ligand 2 |
625 |
0.68 |
chrX_52790931_52792300 | 2.83 |
Ccdc160 |
coiled-coil domain containing 160 |
415 |
0.73 |
chr10_112271302_112272238 | 2.82 |
Kcnc2 |
potassium voltage gated channel, Shaw-related subfamily, member 2 |
649 |
0.75 |
chr4_25799045_25800424 | 2.80 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr16_44556225_44556470 | 2.79 |
Mir3081 |
microRNA 3081 |
1782 |
0.34 |
chr7_44441951_44442938 | 2.79 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr2_180385943_180386992 | 2.78 |
B230312C02Rik |
RIKEN cDNA B230312C02 gene |
582 |
0.63 |
chr4_151103820_151105079 | 2.76 |
Camta1 |
calmodulin binding transcription activator 1 |
3854 |
0.22 |
chr7_139833633_139836105 | 2.74 |
Adgra1 |
adhesion G protein-coupled receptor A1 |
93 |
0.96 |
chr13_55486580_55486765 | 2.73 |
Dbn1 |
drebrin 1 |
12 |
0.94 |
chr17_71869276_71870182 | 2.73 |
Clip4 |
CAP-GLY domain containing linker protein family, member 4 |
13443 |
0.21 |
chr5_110386046_110387130 | 2.72 |
Fbrsl1 |
fibrosin-like 1 |
374 |
0.79 |
chr8_12385818_12386491 | 2.71 |
Sox1ot |
Sox1 overlapping transcript |
383 |
0.8 |
chr15_98003545_98005314 | 2.71 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr7_65155644_65156419 | 2.70 |
Fam189a1 |
family with sequence similarity 189, member A1 |
385 |
0.85 |
chr15_83780142_83780827 | 2.69 |
Mpped1 |
metallophosphoesterase domain containing 1 |
461 |
0.86 |
chr11_32347856_32348672 | 2.67 |
Sh3pxd2b |
SH3 and PX domains 2B |
424 |
0.81 |
chrX_6091588_6092836 | 2.67 |
Gm26618 |
predicted gene, 26618 |
57 |
0.96 |
chr7_4120918_4121688 | 2.66 |
9430041J12Rik |
RIKEN cDNA 9430041J12 gene |
575 |
0.45 |
chr17_46486770_46487488 | 2.66 |
Ttbk1 |
tau tubulin kinase 1 |
546 |
0.61 |
chrX_57503221_57504242 | 2.65 |
Gpr101 |
G protein-coupled receptor 101 |
26 |
0.98 |
chr1_124045018_124046369 | 2.62 |
Dpp10 |
dipeptidylpeptidase 10 |
134 |
0.98 |
chr2_57102068_57103416 | 2.60 |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
10330 |
0.2 |
chr1_72824497_72825693 | 2.60 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
227 |
0.94 |
chrX_86191680_86192868 | 2.59 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr16_94996546_94998023 | 2.58 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
32 |
0.99 |
chr12_29534253_29535510 | 2.58 |
Gm20208 |
predicted gene, 20208 |
10 |
0.8 |
chr4_74013098_74014374 | 2.57 |
Frmd3 |
FERM domain containing 3 |
292 |
0.91 |
chr13_110279614_110280243 | 2.57 |
Rab3c |
RAB3C, member RAS oncogene family |
222 |
0.95 |
chr6_53819040_53819677 | 2.57 |
Gm16499 |
predicted gene 16499 |
615 |
0.65 |
chr19_19108280_19109261 | 2.56 |
Rorb |
RAR-related orphan receptor beta |
2426 |
0.42 |
chr15_89453545_89454765 | 2.56 |
Mapk8ip2 |
mitogen-activated protein kinase 8 interacting protein 2 |
242 |
0.82 |
chr9_16499783_16502054 | 2.56 |
Fat3 |
FAT atypical cadherin 3 |
367 |
0.92 |
chr12_49400835_49402156 | 2.55 |
Gm48659 |
predicted gene, 48659 |
10753 |
0.13 |
chr10_81257208_81258396 | 2.55 |
Matk |
megakaryocyte-associated tyrosine kinase |
28 |
0.92 |
chr11_106019908_106020882 | 2.55 |
Kcnh6 |
potassium voltage-gated channel, subfamily H (eag-related), member 6 |
6622 |
0.1 |
chr8_122335750_122336915 | 2.54 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr3_45379351_45381850 | 2.54 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr12_108274109_108275128 | 2.53 |
Ccdc85c |
coiled-coil domain containing 85C |
515 |
0.78 |
chr1_63309029_63310075 | 2.53 |
Gm23448 |
predicted gene, 23448 |
9169 |
0.12 |
chr5_128952013_128953618 | 2.53 |
Rimbp2 |
RIMS binding protein 2 |
218 |
0.95 |
chr11_19008700_19009431 | 2.53 |
Gm16140 |
predicted gene 16140 |
63 |
0.96 |
chr8_121730928_121732115 | 2.53 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr3_107516925_107518261 | 2.51 |
Slc6a17 |
solute carrier family 6 (neurotransmitter transporter), member 17 |
156 |
0.95 |
chr7_123982468_123983092 | 2.51 |
Hs3st4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
89 |
0.91 |
chr6_100704458_100705765 | 2.51 |
Gxylt2 |
glucoside xylosyltransferase 2 |
356 |
0.85 |
chr14_96517868_96518996 | 2.51 |
Klhl1 |
kelch-like 1 |
670 |
0.78 |
chr2_125505305_125506423 | 2.51 |
Fbn1 |
fibrillin 1 |
208 |
0.86 |
chr3_55461381_55462661 | 2.51 |
Dclk1 |
doublecortin-like kinase 1 |
49 |
0.97 |
chr6_105676979_105678296 | 2.50 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr3_55242295_55243824 | 2.50 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr18_37089669_37090791 | 2.50 |
Pcdhac1 |
protocadherin alpha subfamily C, 1 |
217 |
0.88 |
chr12_108004209_108004402 | 2.50 |
Bcl11b |
B cell leukemia/lymphoma 11B |
703 |
0.79 |
chr7_99267573_99269343 | 2.49 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr11_76466993_76468433 | 2.49 |
Abr |
active BCR-related gene |
585 |
0.77 |
chr2_181763361_181764530 | 2.48 |
Myt1 |
myelin transcription factor 1 |
613 |
0.66 |
chr11_78490542_78491406 | 2.47 |
Sarm1 |
sterile alpha and HEAT/Armadillo motif containing 1 |
3679 |
0.1 |
chr5_111418246_111419747 | 2.46 |
Mn1 |
meningioma 1 |
1554 |
0.34 |
chr2_102450383_102451888 | 2.46 |
Fjx1 |
four jointed box 1 |
1364 |
0.51 |
chr9_108824114_108825614 | 2.46 |
Gm35025 |
predicted gene, 35025 |
3 |
0.87 |
chr10_81229656_81230911 | 2.45 |
Atcay |
ataxia, cerebellar, Cayman type |
502 |
0.53 |
chrX_147552812_147553925 | 2.44 |
Lrch2 |
leucine-rich repeats and calponin homology (CH) domain containing 2 |
682 |
0.76 |
chr5_142962041_142962731 | 2.42 |
Fscn1 |
fascin actin-bundling protein 1 |
567 |
0.73 |
chr16_26967704_26968435 | 2.42 |
Gmnc |
geminin coiled-coil domain containing |
176 |
0.97 |
chr4_4137903_4139262 | 2.41 |
Penk |
preproenkephalin |
105 |
0.72 |
chr13_40727690_40728914 | 2.41 |
Gm26688 |
predicted gene, 26688 |
494 |
0.48 |
chr15_34837199_34838365 | 2.40 |
Kcns2 |
K+ voltage-gated channel, subfamily S, 2 |
267 |
0.93 |
chr6_18169814_18171281 | 2.40 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
140 |
0.95 |
chr14_4498814_4499998 | 2.40 |
Gm3173 |
predicted gene 3173 |
15352 |
0.11 |
chr18_77560987_77561705 | 2.39 |
Rnf165 |
ring finger protein 165 |
3263 |
0.29 |
chr18_76843674_76844984 | 2.39 |
Skor2 |
SKI family transcriptional corepressor 2 |
12076 |
0.24 |
chr12_95691954_95693678 | 2.38 |
Flrt2 |
fibronectin leucine rich transmembrane protein 2 |
590 |
0.73 |
chr7_141428600_141429722 | 2.38 |
Cend1 |
cell cycle exit and neuronal differentiation 1 |
190 |
0.82 |
chr4_129514999_129515150 | 2.37 |
Marcksl1 |
MARCKS-like 1 |
1493 |
0.2 |
chr6_93911862_93913573 | 2.36 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr6_112946102_112946968 | 2.36 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
219 |
0.74 |
chr13_96130949_96131570 | 2.36 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1318 |
0.36 |
chr2_152081612_152083149 | 2.35 |
Scrt2 |
scratch family zinc finger 2 |
851 |
0.52 |
chr5_120710211_120711265 | 2.35 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chr3_29082041_29083319 | 2.35 |
Egfem1 |
EGF-like and EMI domain containing 1 |
53 |
0.98 |
chr19_4711641_4712943 | 2.35 |
Sptbn2 |
spectrin beta, non-erythrocytic 2 |
92 |
0.94 |
chrX_137569718_137571626 | 2.35 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
64 |
0.98 |
chr17_17828911_17829692 | 2.34 |
Mir99b |
microRNA 99b |
887 |
0.24 |
chr15_82274909_82275956 | 2.33 |
Septin3 |
septin 3 |
32 |
0.94 |
chr5_37821115_37822599 | 2.33 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr18_58837303_58837928 | 2.33 |
Adamts19 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 19 |
298 |
0.94 |
chr14_123626367_123627548 | 2.32 |
Nalcn |
sodium leak channel, non-selective |
4 |
0.98 |
chr19_31663709_31664998 | 2.32 |
Prkg1 |
protein kinase, cGMP-dependent, type I |
17 |
0.99 |
chr13_48262938_48263089 | 2.32 |
A330033J07Rik |
RIKEN cDNA A330033J07 gene |
390 |
0.47 |
chr10_40024345_40025318 | 2.30 |
Mfsd4b1 |
major facilitator superfamily domain containing 4B1 |
328 |
0.82 |
chr4_134251059_134252406 | 2.30 |
Grrp1 |
glycine/arginine rich protein 1 |
1291 |
0.24 |
chr2_157914223_157915670 | 2.29 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr14_4110158_4111243 | 2.29 |
Gm8108 |
predicted gene 8108 |
174 |
0.93 |
chr5_25222603_25223750 | 2.28 |
E130116L18Rik |
RIKEN cDNA E130116L18 gene |
23 |
0.81 |
chr3_25143527_25144623 | 2.28 |
Gm37136 |
predicted gene, 37136 |
7 |
0.71 |
chr5_36868663_36870303 | 2.28 |
Ppp2r2c |
protein phosphatase 2, regulatory subunit B, gamma |
820 |
0.55 |
chr14_4649261_4650460 | 2.27 |
Gm3239 |
predicted gene 3239 |
14332 |
0.11 |
chr12_67220702_67221169 | 2.26 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
107 |
0.98 |
chr14_12822570_12823126 | 2.26 |
Cadps |
Ca2+-dependent secretion activator |
197 |
0.96 |
chr17_11664263_11665109 | 2.25 |
Gm10513 |
predicted gene 10513 |
67659 |
0.13 |
chr8_121651047_121652249 | 2.24 |
Zcchc14 |
zinc finger, CCHC domain containing 14 |
1253 |
0.31 |
chr7_87584098_87584781 | 2.24 |
Grm5 |
glutamate receptor, metabotropic 5 |
41 |
0.99 |
chr2_19445307_19446756 | 2.23 |
Ptf1a |
pancreas specific transcription factor, 1a |
368 |
0.62 |
chr6_85483808_85485100 | 2.22 |
Fbxo41 |
F-box protein 41 |
18404 |
0.11 |
chr8_10006376_10007861 | 2.22 |
Tnfsf13b |
tumor necrosis factor (ligand) superfamily, member 13b |
464 |
0.78 |
chr11_60141098_60141590 | 2.21 |
Rai1 |
retinoic acid induced 1 |
1085 |
0.44 |
chr1_158362036_158363261 | 2.21 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr8_111889675_111890918 | 2.21 |
Gm23853 |
predicted gene, 23853 |
10992 |
0.13 |
chr5_25768817_25769129 | 2.21 |
Actr3b |
ARP3 actin-related protein 3B |
8934 |
0.19 |
chr14_37097809_37098787 | 2.21 |
Cdhr1 |
cadherin-related family member 1 |
49 |
0.97 |
chr15_100871055_100872065 | 2.21 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
140 |
0.96 |
chr11_79590775_79591929 | 2.21 |
Rab11fip4 |
RAB11 family interacting protein 4 (class II) |
140 |
0.93 |
chr4_129105196_129105950 | 2.20 |
Tmem54 |
transmembrane protein 54 |
1 |
0.96 |
chr2_172040251_172043672 | 2.20 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr7_57591075_57592137 | 2.20 |
Gabrb3 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
76 |
0.98 |
chr15_66285652_66286618 | 2.20 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
84 |
0.93 |
chr7_45240555_45241594 | 2.19 |
Slc6a16 |
solute carrier family 6, member 16 |
11 |
0.92 |
chr7_129256430_129257706 | 2.19 |
Plpp4 |
phospholipid phosphatase 4 |
13 |
0.99 |
chrX_58030987_58032527 | 2.18 |
Zic3 |
zinc finger protein of the cerebellum 3 |
747 |
0.74 |
chr17_42315796_42317065 | 2.18 |
Ptchd4 |
patched domain containing 4 |
170 |
0.98 |
chr15_103537057_103538269 | 2.18 |
Ppp1r1a |
protein phosphatase 1, regulatory inhibitor subunit 1A |
331 |
0.84 |
chr4_115133068_115134495 | 2.18 |
Cyp4x1os |
cytochrome P450, family 4, subfamily x, polypeptide 1, opposite strand |
51 |
0.69 |
chr8_17534365_17535810 | 2.18 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr15_92598307_92599654 | 2.18 |
Pdzrn4 |
PDZ domain containing RING finger 4 |
1854 |
0.49 |
chr18_58209161_58210138 | 2.17 |
Fbn2 |
fibrillin 2 |
277 |
0.94 |
chr4_136834052_136834430 | 2.17 |
Ephb2 |
Eph receptor B2 |
1602 |
0.38 |
chrX_7919510_7921219 | 2.17 |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
542 |
0.52 |
chr8_14382368_14383445 | 2.17 |
Dlgap2 |
DLG associated protein 2 |
910 |
0.66 |
chr7_79501250_79502506 | 2.16 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr14_21984849_21986226 | 2.16 |
Zfp503 |
zinc finger protein 503 |
4064 |
0.17 |
chr7_137309191_137310700 | 2.16 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr11_11115362_11116603 | 2.16 |
Vwc2 |
von Willebrand factor C domain containing 2 |
131 |
0.97 |
chr9_27299227_27300541 | 2.15 |
Igsf9b |
immunoglobulin superfamily, member 9B |
656 |
0.72 |
chr13_72627158_72627802 | 2.15 |
Gm20554 |
predicted gene, 20554 |
1084 |
0.43 |
chr8_75212749_75213165 | 2.15 |
Rasd2 |
RASD family, member 2 |
987 |
0.5 |
chr8_123643382_123644122 | 2.14 |
Rhou |
ras homolog family member U |
10177 |
0.04 |
chr3_31097203_31098928 | 2.14 |
Skil |
SKI-like |
1232 |
0.48 |
chr1_42697110_42697488 | 2.14 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
1531 |
0.26 |
chr15_87544354_87545329 | 2.13 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr13_71958597_71960663 | 2.13 |
Irx1 |
Iroquois homeobox 1 |
197 |
0.95 |
chr6_103510606_103512502 | 2.12 |
Chl1 |
cell adhesion molecule L1-like |
224 |
0.93 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.3 | 7.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
2.1 | 2.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
2.0 | 2.0 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
2.0 | 6.0 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
2.0 | 10.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.6 | 6.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.6 | 1.6 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.5 | 4.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
1.5 | 8.9 | GO:0060174 | limb bud formation(GO:0060174) |
1.5 | 4.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.4 | 4.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.4 | 2.7 | GO:0021550 | medulla oblongata development(GO:0021550) |
1.4 | 5.4 | GO:0030035 | microspike assembly(GO:0030035) |
1.4 | 5.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.4 | 4.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
1.3 | 3.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.3 | 3.9 | GO:0001757 | somite specification(GO:0001757) |
1.3 | 3.8 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.3 | 3.8 | GO:0048880 | sensory system development(GO:0048880) |
1.3 | 3.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.3 | 6.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.3 | 3.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
1.2 | 5.0 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
1.2 | 3.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.2 | 3.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
1.2 | 6.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.2 | 4.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.2 | 7.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.2 | 2.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.2 | 3.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.2 | 3.5 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
1.1 | 2.3 | GO:0051795 | positive regulation of catagen(GO:0051795) |
1.1 | 4.5 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.1 | 3.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.1 | 2.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.1 | 2.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
1.1 | 4.4 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.1 | 3.3 | GO:0046958 | nonassociative learning(GO:0046958) |
1.1 | 5.4 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.1 | 4.3 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.1 | 1.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.1 | 3.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.1 | 1.1 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.0 | 3.1 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.0 | 3.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.0 | 4.1 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 7.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.0 | 2.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.0 | 3.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
1.0 | 3.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.0 | 2.0 | GO:0060594 | mammary gland specification(GO:0060594) |
1.0 | 7.8 | GO:0071625 | vocalization behavior(GO:0071625) |
0.9 | 2.8 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.9 | 8.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.9 | 2.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.9 | 9.4 | GO:0001975 | response to amphetamine(GO:0001975) |
0.9 | 1.9 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
0.9 | 23.2 | GO:0001964 | startle response(GO:0001964) |
0.9 | 16.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 2.8 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.9 | 6.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.9 | 2.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.9 | 2.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.9 | 4.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.9 | 3.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.9 | 2.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
0.9 | 7.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.9 | 4.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.9 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.9 | 2.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.9 | 3.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.8 | 1.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 1.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.8 | 2.5 | GO:0015888 | thiamine transport(GO:0015888) |
0.8 | 2.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.8 | 1.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.8 | 1.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.8 | 4.7 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.8 | 3.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 1.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.8 | 2.3 | GO:0030070 | insulin processing(GO:0030070) |
0.8 | 2.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.8 | 0.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.8 | 3.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.8 | 0.8 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.8 | 1.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.8 | 6.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.8 | 2.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.7 | 24.7 | GO:0019228 | neuronal action potential(GO:0019228) |
0.7 | 2.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.7 | 1.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.7 | 2.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.7 | 1.4 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.7 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 8.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 3.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 3.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.7 | 2.7 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.7 | 4.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.7 | 3.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.7 | 1.4 | GO:0009629 | response to gravity(GO:0009629) |
0.7 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.7 | 0.7 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.7 | 3.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.7 | 2.7 | GO:0061743 | motor learning(GO:0061743) |
0.7 | 5.4 | GO:0034776 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.7 | 2.7 | GO:0098868 | bone growth(GO:0098868) |
0.7 | 0.7 | GO:0036166 | phenotypic switching(GO:0036166) |
0.7 | 7.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.7 | 1.3 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.7 | 1.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.7 | 3.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.7 | 3.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 1.9 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.6 | 1.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.6 | 1.3 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 9.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.6 | 1.9 | GO:1905049 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.6 | 1.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 0.6 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 1.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 1.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 1.9 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 1.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.6 | 1.2 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.6 | 1.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.6 | 0.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.6 | 3.0 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 1.2 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.6 | 0.6 | GO:1903416 | response to glycoside(GO:1903416) |
0.6 | 2.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.6 | 2.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 2.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 3.0 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.6 | 4.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 2.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.6 | 1.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.6 | 1.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.6 | 45.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.6 | 27.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.6 | 1.7 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.6 | 2.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 2.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 1.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 1.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.6 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.6 | 1.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.6 | 1.1 | GO:0007412 | axon target recognition(GO:0007412) |
0.6 | 0.6 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.5 | 2.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.5 | 1.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.5 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 1.1 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.5 | 2.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.5 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 3.6 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.5 | 1.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.5 | 1.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 3.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.5 | 1.5 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 1.5 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 3.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 1.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.5 | 1.0 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.5 | 0.5 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 2.0 | GO:0007442 | hindgut morphogenesis(GO:0007442) |
0.5 | 2.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.5 | 2.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.5 | 1.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.5 | 1.5 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.5 | 7.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.5 | 1.5 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.5 | 1.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.5 | 1.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 1.5 | GO:0008306 | associative learning(GO:0008306) |
0.5 | 2.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.5 | 1.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 2.8 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 1.9 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.5 | 1.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.5 | 1.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 2.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.5 | 0.9 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.5 | 2.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.5 | 1.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.5 | 1.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.5 | 3.6 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.4 | 2.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.4 | 0.9 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.4 | 1.3 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.4 | 0.9 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
0.4 | 2.2 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.4 | 0.4 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
0.4 | 1.3 | GO:0042637 | catagen(GO:0042637) |
0.4 | 1.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.4 | 0.9 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.4 | 0.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 0.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.4 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 0.9 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.4 | 6.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.4 | 0.8 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.4 | 1.3 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 0.4 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.4 | 1.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.4 | 2.1 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 1.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 2.5 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.4 | 3.7 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 1.6 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.4 | 2.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 1.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 1.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 1.2 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.4 | 1.2 | GO:0050955 | thermoception(GO:0050955) |
0.4 | 1.6 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.4 | 3.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.4 | 0.8 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.4 | 1.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.4 | 0.8 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.4 | 3.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.4 | 0.4 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.4 | 0.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.4 | 0.8 | GO:0072198 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
0.4 | 1.9 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.4 | 6.9 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.4 | 1.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.4 | 0.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 2.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.4 | 2.2 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.4 | 4.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.4 | 0.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 0.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 0.4 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.4 | 1.5 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 1.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.4 | 1.4 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.4 | 4.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 1.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 0.4 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 0.7 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.4 | 0.7 | GO:0035106 | operant conditioning(GO:0035106) |
0.4 | 1.8 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.4 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.4 | 1.1 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.4 | 1.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.4 | 1.1 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 1.7 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.3 | 1.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 1.4 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 1.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 1.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.3 | 2.8 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.3 | 1.7 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.3 | 3.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 0.3 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.3 | 0.7 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.3 | 1.0 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 1.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.3 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.3 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 2.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.3 | 1.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 1.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.3 | 1.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.3 | 2.3 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 1.3 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 1.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 0.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 0.6 | GO:0060026 | convergent extension(GO:0060026) |
0.3 | 1.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 3.8 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.3 | 0.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.3 | 1.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 1.2 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.3 | 1.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 0.6 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.2 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.3 | 1.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.3 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.3 | 4.0 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 0.9 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.3 | 2.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 0.6 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.3 | 0.6 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.3 | 4.6 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.3 | 1.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 5.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.3 | 2.7 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.3 | 1.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.3 | 1.8 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.3 | 0.3 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.3 | 4.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.3 | 5.1 | GO:0007616 | long-term memory(GO:0007616) |
0.3 | 0.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 1.2 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 1.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.3 | 3.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.3 | 1.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.9 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
0.3 | 1.7 | GO:0043084 | penile erection(GO:0043084) |
0.3 | 0.3 | GO:0070305 | response to cGMP(GO:0070305) |
0.3 | 0.9 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.3 | 2.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.9 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 2.6 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 0.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 1.1 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.3 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.6 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 2.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 7.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 0.3 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.3 | 0.8 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 1.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 1.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.3 | 8.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.3 | 0.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 1.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.3 | 0.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.3 | 0.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 0.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 0.5 | GO:0022038 | corpus callosum development(GO:0022038) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 0.3 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.3 | 3.5 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.3 | 2.7 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.3 | 0.3 | GO:0061525 | hindgut development(GO:0061525) |
0.3 | 1.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.3 | 0.5 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 6.1 | GO:0008542 | visual learning(GO:0008542) |
0.3 | 1.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 1.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.3 | 1.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.5 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.3 | 1.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.3 | 1.0 | GO:0021756 | striatum development(GO:0021756) |
0.3 | 0.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 0.8 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.3 | 1.5 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.3 | 0.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 1.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.5 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 1.0 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 0.2 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.2 | 1.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.2 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.5 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 2.2 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 0.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.2 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.2 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.2 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.2 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 3.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 0.7 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 0.7 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.2 | 0.7 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 0.7 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 1.2 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.7 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.4 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 0.2 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 0.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.2 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.2 | 5.2 | GO:0060612 | adipose tissue development(GO:0060612) |
0.2 | 0.2 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.2 | 1.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.2 | 0.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.2 | 0.7 | GO:1904220 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 2.2 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.7 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 1.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 0.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 1.5 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.2 | 0.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.2 | 0.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.2 | 0.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.4 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.2 | 5.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 11.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.2 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.4 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 0.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 1.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.4 | GO:0035989 | tendon development(GO:0035989) |
0.2 | 0.2 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.4 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.2 | 0.2 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.4 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 0.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 1.0 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 2.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 2.1 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 1.5 | GO:0021575 | hindbrain morphogenesis(GO:0021575) |
0.2 | 1.0 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.8 | GO:0031652 | regulation of heat generation(GO:0031650) positive regulation of heat generation(GO:0031652) |
0.2 | 1.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 0.4 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 2.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 0.9 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.2 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.2 | 1.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.2 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 1.1 | GO:0015846 | polyamine transport(GO:0015846) |
0.2 | 3.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 1.8 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.2 | 1.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.9 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
0.2 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 1.1 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 1.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.2 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 10.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.2 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.2 | 0.3 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.5 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.3 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 0.7 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 0.8 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.2 | 1.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.2 | 1.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.2 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 1.3 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.2 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 0.5 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 0.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.2 | 0.3 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.2 | 0.3 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 1.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 1.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.3 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 1.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 2.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 1.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.2 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 4.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.2 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 1.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 1.6 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.2 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.2 | 0.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.3 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.3 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.4 | GO:0046349 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
0.1 | 0.4 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 1.0 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 8.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.4 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.1 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 1.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.6 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
0.1 | 0.8 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.3 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.3 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.5 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.4 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.1 | 0.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.4 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.1 | 0.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.7 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.4 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.1 | 1.4 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.6 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.3 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 0.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.1 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.1 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 0.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 0.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 1.2 | GO:0021879 | forebrain neuron differentiation(GO:0021879) |
0.1 | 0.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 1.6 | GO:0032401 | establishment of melanosome localization(GO:0032401) |
0.1 | 0.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.3 | GO:0042891 | antibiotic transport(GO:0042891) |
0.1 | 0.3 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 2.2 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 2.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.9 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 1.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.4 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 3.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.8 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.1 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.1 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 0.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
0.1 | 0.1 | GO:0003130 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
0.1 | 0.3 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.3 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 2.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.4 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.7 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.3 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.2 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.2 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 2.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to axon(GO:0099612) |
0.1 | 0.7 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.1 | 4.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.2 | GO:0044314 | protein K29-linked ubiquitination(GO:0035519) protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.1 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.1 | 0.1 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 1.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.1 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.1 | 0.3 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.1 | 0.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.3 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.1 | 1.6 | GO:0050905 | neuromuscular process(GO:0050905) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.7 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.1 | 0.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.9 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.2 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 1.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.4 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.1 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.1 | 0.1 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.1 | 0.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.8 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.4 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 0.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.8 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 0.5 | GO:0022037 | metencephalon development(GO:0022037) |
0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.4 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.1 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.5 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.3 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.1 | GO:0061724 | lipophagy(GO:0061724) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) |
0.1 | 0.1 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 0.4 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.1 | 0.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.1 | 0.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.1 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.6 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.2 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.1 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.2 | GO:0015744 | succinate transport(GO:0015744) |
0.1 | 0.7 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.6 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.1 | 0.2 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.1 | 0.3 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.1 | 0.1 | GO:0035822 | meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
0.1 | 0.1 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.1 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 1.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.1 | 0.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.0 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.2 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.0 | 0.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.3 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0048382 | mesendoderm development(GO:0048382) |
0.0 | 0.1 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.0 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.0 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.0 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.0 | 0.2 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.0 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.2 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.0 | GO:0002434 | immune complex clearance(GO:0002434) |
0.0 | 0.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.0 | 0.0 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
0.0 | 0.1 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.1 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.0 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.1 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.0 | 0.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.0 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
0.0 | 0.0 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.0 | GO:0015817 | histidine transport(GO:0015817) |
0.0 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.0 | 0.0 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.0 | 0.0 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.0 | GO:0021872 | forebrain generation of neurons(GO:0021872) |
0.0 | 0.0 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.0 | 0.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.0 | 0.0 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.0 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.0 | 0.0 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.0 | 0.0 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.0 | 0.0 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.0 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.0 | GO:0036257 | multivesicular body organization(GO:0036257) multivesicular body assembly(GO:0036258) late endosomal microautophagy(GO:0061738) |
0.0 | 0.0 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.0 | 0.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.0 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.1 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.0 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.0 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.0 | 0.0 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.0 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.0 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 6.0 | GO:0044308 | axonal spine(GO:0044308) |
1.4 | 4.2 | GO:0044393 | microspike(GO:0044393) |
1.3 | 15.4 | GO:0043194 | axon initial segment(GO:0043194) |
1.1 | 13.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.1 | 3.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.0 | 6.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.9 | 1.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 4.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.9 | 2.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.8 | 5.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.8 | 0.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.8 | 2.3 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 6.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 23.4 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 12.6 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.7 | 2.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 2.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.7 | 2.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.7 | 2.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 2.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.6 | 1.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.6 | 1.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 1.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 40.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 3.3 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.5 | 2.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.5 | 1.6 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 7.9 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.5 | 2.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 1.0 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.5 | 8.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.5 | 2.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 2.9 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 5.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 0.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.5 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 5.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.4 | 6.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.4 | 3.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 0.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 1.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 1.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 43.1 | GO:0043204 | perikaryon(GO:0043204) |
0.4 | 3.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.4 | 1.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 3.9 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 10.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.4 | 49.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.4 | 1.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 1.1 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 0.7 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 1.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 3.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 0.7 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 2.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 4.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 5.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.3 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.3 | 6.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 3.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.3 | 2.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 2.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 0.3 | GO:0044298 | cell body membrane(GO:0044298) |
0.3 | 1.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 0.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 6.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 1.3 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 2.4 | GO:0060091 | kinocilium(GO:0060091) |
0.3 | 0.8 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 2.7 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 5.3 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 3.6 | GO:0043679 | axon terminus(GO:0043679) |
0.3 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 2.7 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.2 | 0.7 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 1.0 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 4.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 1.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 28.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.2 | 0.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.2 | 1.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.8 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 0.2 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.2 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 1.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 0.9 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.5 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 3.2 | GO:0097060 | synaptic membrane(GO:0097060) |
0.2 | 9.0 | GO:0030426 | growth cone(GO:0030426) |
0.2 | 0.9 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 1.4 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 2.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.9 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.1 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 3.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.4 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.3 | GO:0005818 | aster(GO:0005818) |
0.1 | 0.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 3.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 1.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 1.5 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 2.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 26.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 39.1 | GO:0045202 | synapse(GO:0045202) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.2 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 4.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.2 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 5.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.3 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.1 | 0.3 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.1 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 1.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.4 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 0.8 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 1.0 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 15.6 | GO:0043005 | neuron projection(GO:0043005) |
0.0 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.4 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.5 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 2.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 1.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.0 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.9 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.0 | 10.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.5 | 11.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.4 | 7.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.4 | 10.8 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.3 | 7.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
1.3 | 6.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.3 | 3.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.2 | 4.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.2 | 6.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 4.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.1 | 3.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.0 | 1.0 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
1.0 | 2.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.0 | 3.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
1.0 | 4.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 2.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.0 | 4.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 1.0 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.9 | 7.5 | GO:0008066 | glutamate receptor activity(GO:0008066) G-protein coupled glutamate receptor activity(GO:0098988) |
0.9 | 0.9 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.9 | 3.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.9 | 3.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 2.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.8 | 2.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.8 | 1.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.8 | 2.5 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 2.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.8 | 2.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.8 | 2.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 3.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.8 | 3.0 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.7 | 2.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.7 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.7 | 2.2 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 1.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.7 | 3.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.6 | 1.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 1.9 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.6 | 3.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.6 | 1.2 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 3.0 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 10.1 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.6 | 3.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 1.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.6 | 17.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 10.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.6 | 10.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.6 | 7.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 2.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.5 | 2.2 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.5 | 1.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 4.9 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 4.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.5 | 2.2 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.5 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.5 | 3.7 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.5 | 1.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.5 | 1.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.5 | 1.5 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.5 | 0.5 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.5 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 2.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 1.5 | GO:0018565 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.5 | 7.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.5 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.5 | 1.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 2.4 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 0.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 1.9 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.5 | 2.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 1.8 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 2.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.4 | 1.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.4 | 1.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.4 | 1.3 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.4 | 7.8 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 6.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.4 | 2.6 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.4 | 0.4 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 2.1 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.4 | 2.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.4 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.4 | 12.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.4 | 9.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.4 | 9.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 4.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.4 | 1.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.4 | 1.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.4 | 3.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 16.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 4.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.4 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 4.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.4 | 1.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.4 | 3.4 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 1.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.4 | 1.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 1.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.4 | 1.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 3.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.4 | 4.4 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.4 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.4 | 8.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.4 | 0.4 | GO:0035240 | dopamine binding(GO:0035240) catecholamine binding(GO:1901338) |
0.4 | 2.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.3 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 0.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.3 | 2.0 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.3 | 7.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.3 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.3 | 4.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 3.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.3 | 1.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 3.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.0 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.3 | 3.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.3 | 2.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 6.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 1.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 2.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.3 | 1.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 9.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 5.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 1.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.8 | GO:0036122 | BMP binding(GO:0036122) |
0.3 | 5.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.3 | 3.6 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 0.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.3 | 13.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 4.3 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.3 | 4.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.7 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.3 | 1.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.3 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.3 | 3.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.3 | 3.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.3 | 7.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.3 | 0.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.3 | 1.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 1.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.3 | 0.3 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.3 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 3.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.3 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.2 | 7.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.2 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.2 | 4.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.2 | 0.7 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.2 | 1.0 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.2 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 3.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 0.7 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.7 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) |
0.2 | 7.0 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 0.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.2 | 0.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.2 | 2.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 6.0 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.2 | 2.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 3.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.2 | 1.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.2 | 2.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.9 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.2 | 5.1 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 0.9 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 1.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 4.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 0.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.2 | 0.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 3.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 0.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 1.0 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.2 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 0.8 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.2 | 2.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.2 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 4.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 1.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 3.2 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 0.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 18.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 0.5 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.2 | 7.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 2.1 | GO:0022840 | leak channel activity(GO:0022840) potassium ion leak channel activity(GO:0022841) narrow pore channel activity(GO:0022842) |
0.2 | 1.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 1.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 0.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.2 | 0.5 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 0.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 1.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 2.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 5.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.2 | 2.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.5 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.2 | 4.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 2.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 1.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.5 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.2 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.2 | 4.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 0.8 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 1.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 0.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.1 | 1.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 1.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.1 | 0.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.5 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 1.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.1 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 4.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 1.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 2.0 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.5 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.1 | 1.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 45.7 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 2.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.4 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 2.3 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 0.9 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.1 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.1 | 0.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.4 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 1.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.1 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.1 | 0.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.1 | 1.0 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.7 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.0 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.9 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.4 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 4.2 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 0.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 0.2 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.4 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.1 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 0.1 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.2 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.1 | 0.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.1 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.1 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.3 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.9 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.0 | GO:0005119 | smoothened binding(GO:0005119) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.0 | 1.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.9 | GO:0005262 | calcium channel activity(GO:0005262) |
0.0 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.3 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.0 | 0.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.0 | 0.1 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0008495 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.0 | 0.1 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.0 | 0.1 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.0 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.4 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.0 | 0.6 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.0 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.0 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.3 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.0 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.0 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0019838 | growth factor binding(GO:0019838) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.5 | 5.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 10.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.4 | 1.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 3.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 1.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 5.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 9.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 4.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 53.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 10.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 3.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 6.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 4.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 6.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 9.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.3 | 13.5 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 4.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 5.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 0.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 2.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 7.7 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 6.7 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.2 | 3.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.2 | 2.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 26.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 11.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 3.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.4 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 0.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 3.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.5 | 4.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.0 | 15.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.9 | 10.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 2.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.8 | 2.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.8 | 10.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.7 | 29.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.7 | 7.5 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 6.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.6 | 13.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.5 | 7.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 5.8 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.5 | 6.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.5 | 9.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.5 | 1.5 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.5 | 1.9 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 5.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 15.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.5 | 1.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.4 | 8.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.4 | 6.5 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.4 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 2.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 2.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.3 | 3.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 6.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 1.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 5.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 3.8 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 3.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.3 | 6.1 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.3 | 1.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 4.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 0.5 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.3 | 4.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 1.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 3.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 8.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 1.6 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
0.2 | 1.8 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 4.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 3.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 7.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 15.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.2 | 4.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 1.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.2 | 3.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 27.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 0.9 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 2.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 3.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 0.8 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.2 | 1.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 2.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 2.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.1 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 1.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.4 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.1 | 1.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 3.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 3.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.1 | 1.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 2.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.0 | 1.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 1.0 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 1.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.3 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.4 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |